The spreadsheet contains calculation of Economic Value Addition for Bonus Payment. This case "VYADERM PHARMACEUTICALS" was taught in Executive Compens...
21-22, December, 2005 NDRI, Karnal, Haryana, India.
EVA Calculations
Vyaderm Solution
Negotiable Instruments Law
.
Full description
Economic Value of TimeFull description
Nayan (P10X05) IIM Ranchi Exchange student
Economic value added Calculation for the Net Operating Profit After Tax Operating Earnings + Capitalization of R&D + Capitalization of Advertizing + Goodwill Amortization added back + Restructuring add-back Net Operating Profit before Taxes (NOPBT) - Taxes Net Operating Profit after Taxes (NOPAT) - Capital Charge @ 11%
Economic Value Added EVA Improvement in the year 2000
Calculation of Bonus for year 2000 Managers Base Salary Bonus Target {(60% of Base Salary (100% based on division EVA)} EVA Improvement Goal EVA Target EVA Interval Manager Base Salary Bonus Target(100% based on division EVA) EVA Performance Calculation of Bonus for year 2000 (I) New Bank Balance for Bonus Payout (II) Bonus Payout in the year 2000 (Answer to Question No 2)
Ending Balance (I - II)
Economic value added Calculation for the Net Operating Profit After Tax Operating Earnings + Capitalization of R&D
+ Capitalization of Advertizing + Goodwill Amortization added back + Restructuring add-back Net Operating Profit before Taxes (NOPBT) - Taxes Net Operating Profit after Taxes (NOPAT) - Capital Charge @ 11%
Economic Value Added EVA Improvement in the year 2001
Bonus Estimation for the year 2001 based on the u Managers Base Salary Bonus Target {(60% of Base Salary (100% based on division EVA)} EVA Improvement Goal EVA Target EVA Interval Manager Base Salary Bonus Target(100% based on division EVA) EVA Performance Calculation of Bonus for year 2001 Beginning Bonus Bank Balance New Bank Balance for Bonus Payout Bonus Payout in the year 2000 (Answer to Question No 3) Ending Balance
31666.67 Data Insufficient Nil 40731866.67 121700 40610166.67 4467118.33
116081928.67
1 based on the underlined condition 200000 120000 2150000 5070000 12000000 200000 60% -5.68 -681389 275594 -405794 NIL as Balance is negative -405794
36143048.33 -79938880.33
1995 1996 1997 1998 1999 Research and Developemt 1067300 ### ### ### 9327000 Expenses as Reported on P& L 0 1995 2134600 2134600 2134600 2134600 2134600 1996 2497400 2497400 2497400 2497400 1997 2922000 2922000 2922000 1998 3418800 3418800 1999 1865400 2000 2000 R&D Amortization under EVA Cumulative R&D Expense(P&L) ### ### ### ### ### Less: Cumulative 2134600 6766600 ### ### ### Amortization(EVA) Capatalized R&D for EVA Calculation of Capital
###
2000
For Calculating Q.3 2001
39000000 Data Insufficient NA NA 2497400 NA 2922000 2922000 3418800 3418800 1865400 1865400 7800000 7800000 18503600 NA 103191000 Data Insufficient 56635200 Data Insufficient